57.205 Exposure to Blood and Body Fluids

Status: Original and derived artifacts are available for this document.

Download: docx | pdf | html

Exposure to Blood/Body Fluids
Page 1 of 7
*required for saving
Facility ID#: _____________________
Exposure Event #: __________________
*HCW ID#: _____________________
HCW Name, Last: _________________
First: ___________________
Middle: ___________________
*Gender: □ F     □ M     □ Other
*Date of Birth: _____ /_____ /______
*Work Location: ______________________________
*Occupation: ______________________
If occupation is physician, indicate clinical specialty:___________________
Section I – General Exposure Information
1. *Did exposure occur in this facility:
□ Y
□ N
1a. If No, specify name of facility in which exposure occurred: _____________________________

2. *Date of exposure: _____ /_____ /______
3. *Time of exposure: _______ □ AM  □ PM

4. Number of hours on duty: _________
5. Is exposed person a temp/agency employee? □ Y □ N

6. *Location where exposure occurred: ______________

7. *Type of exposure: (Check all that apply)
□ 7a. Percutaneous: Did exposure involve a clean, unused needle or sharp object?
□ Y    □ N (If No, complete Q8, Q9, Section II and Section V-XI)
□ 7b. Mucous membrane (Complete Q8, Q9, Section III and Section V-XI)
□ 7c. Skin: Was skin intact?  □ Y      □ N      □Unknown    (If No, complete Q8, Q9, Section III & Section V-XI)
□ 7d. Bite (Complete Q9 and Section IV-XI)

8. *Type of fluid/tissue involved in exposure: (Check one)
□ Blood/blood products
□ Body fluids: (Check one)
□ Solutions (IV fluid, irrigation, etc.): (Check one)
□ Visibly bloody
□ Visibly bloody
□ Not visibly bloody
□ Not visibly bloody

□ Tissue
If body fluid, indicate one body fluid type:
□ Other (specify): _________________________
□ Amniotic
□ Saliva
□ Unknown
□ CSF
□ Sputum

□ Pericardial
□ Tears
9. *Body site of exposure: (Check all that apply)
□ Peritoneal
□ Urine
□ Hand/finger
□ Foot
□ Pleural
□ Feces/stool
□ Eye
□ Mouth
□ Semen
□ Other (Specify):
□ Arm
□ Nose
□ Synovial
_____________________
□ Leg
□ Other (specify):
□ Vaginal fluid


____________________


Assurance of Confidentiality:  The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).

Public reporting burden of this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS D-74, Atlanta, GA 30333, ATTN:  PRA (0920-0666).

CDC 57.205 (Front), v6.6
Exposure to Blood/Body Fluids
Page 2 of 7
Section II – Percutaneous Injury
1. *Was the needle or sharp object visibly contaminated with blood prior to exposure?  □ Y   □ N

2. Depth of the injury: (Check one)
□ Superficial, surface scratch
□ Deep puncture or wound
□ Moderate, penetrated skin
□ Unknown

3. What needle or sharp object caused the injury (Check one)
□ Device (select one)
□ Non-device sharp object (specify): ___________________
□ Unknown sharp object

Hollow-bore needle
□ Arterial blood collection device
□ Biopsy needle
□ Bone marrow needle
□ Hypodermic needle, attached to syringe
□ Hypodermic needle, attached to IV tubing
□ Unattached hypodermic needle
□ IV catheter – central line
□ IV catheter – peripheral line
□ Huber needle
□ Prefilled cartridge syringe
□ IV stylet
□ Spinal or epidural needle
□ Hemodialysis needle
□ Dental aspirating syringe w/ needle
□ Vacuum tube holder/needle
□ Winged-steel (Butterfly™ type) needle
□ Hollow-bore needle, type unknown
□ Other hollow-bore needle

Suture needle
□ Suture needle



Other solid sharps
□ Bone cutter
□ Bur
□ Electrocautery device
□ Elevator
□ Explorer
□ Extraction forceps
□ File
□ Lancet
□ Microtome blade
□ Pin
□ Razor
□ Retractor
□ Rod (orthopedic)
□ Scaler/curette
□ Scalpel blade
□ Scissors
□ Tenaculum
□ Trocar
□ Wire



Glass
□ Capillary tube
□ Blood collection tube
□ Medication ampule/vial/bottle
□ Pipette
□ Slide
□ Specimen/test/vacuum tube

Plastic
□ Capillary tube
□ Blood collection tube
□ Specimen/test/vacuum tube

Non-sharp safety device
□ Blood culture adapter
□ Catheter securement device
□ IV delivery system
□ Other known device (specify): _________________________________

4. Manufacturer and Model: _____________________________________
Exposure to Blood/Body Fluids
Page 3 of 7
5. Did the needle or other sharp object involved in the injury have a safety feature?   □ Y    □ N

5a. If Yes, indicate type of safety feature: (Check one)   If No, skip to Q6.
□ Bluntable needle, sharp
□ Needle/sharp ejector
□ Hinged guard/shield
□ Mylar wrapping/plastic
□ Retractable needle/sharp
□ Other safety feature (specify):____________________
□ Sliding/gliding guard/shield
□ Unknown safety mechanism

5b. If the device had a safety feature, when did the injury occur? (Check one)
□ Before activation of the safety feature was appropriate
□ Safety feature failed, after activation
□ During activation of the safety feature
□ Safety feature not activated
□ Safety feature improperly activated
□ Other (specify): _____________________________

6. When did the injury occur? (Check one)

□ Before use of the item
□ During or after disposal
□ During use of the item
□ Unknown
□ After use of the item before disposal


7. For what purpose or activity was the sharp device being used? (Check one)
Obtaining a blood specimen percutaneously
□ Performing phlebotomy
□ Performing a fingerstick/heelstick
□ Performing arterial puncture
□ Other blood-sampling procedure

(specify): ___________________________________
Giving a percutaneous injection
□ Giving an IM injection
□ Placing a skin test (e.g., tuberculin, allergy, etc.)
□ Giving a SC injection

Performing a line related procedure
□ Inserting or withdrawing a catheter
□ Injecting into a line or port
□ Obtaining a blood sample from a central or peripheral I.V. line or port
□ Connecting an I.V. line
Performing surgery/autopsy/other invasive procedure
□ Suturing
□ Palpating/exploring
□ Incising
□ Specify procedure: ____________________________
Performing a dental procedure
□ Hygiene (prophylaxis)
□ Oral surgery
□ Restoration (amalgam composite, crown)
□ Simple extraction
□ Root canal
□ Surgical extraction
□ Periodontal surgery

Handling a specimen
□ Transferring BBF into a specimen container
□ Processing specimen
Other
□ Other diagnostic procedure (e.g., thoracentesis)
□ Unknown
□ Other (specify): ____________________________
Exposure to Blood/Body Fluids
Page 4 of 7
8. What was the activity at the time of injury? (Check one)
□ Cleaning room
□ Collecting/transporting waste
□ Decontamination/processing used equipment
□ Disassembling device/equipment
□ Handling equipment
□ Opening/breaking glass container (e.g., ampule)
□ Performing procedure
□ Placing sharp in container
□ Recapping
□ Transferring/passing/receiving device
□ Other (specify): _____________________________________

9. Who was holding the device at the time the injury occurred? (Check one)
□ Exposed person
□ Co-worker/other person
□ No one, the sharp was an uncontrolled sharp in the environment

10. What happened when the injury occurred? (Check one)
□ Patient moved and jarred device
□ Contact with overfilled/punctured sharps container
□ Device slipped
□ Improperly disposed sharp
□ Device rebounded
□ Other (specify): _______________________________
□ Sharp was being recapped
□ Unknown
□ Collided with co-worker or other person


Exposure to Blood/Body Fluids
Page 5 of 7
Section III – Mucous Membrane and/or Skin Exposure
1. Estimate the amount of blood/body fluid exposure: (Check one)
□ Small (<1 tsp or 5cc)
□ Large (> ¼ cup or 50cc)
□ Moderate (>1 tsp and up to ¼ cup, or 6-50 cc)
□ Unknown

2. Activity/event when exposure occurred: (Check one)
□ Airway manipulation (e.g., suctioning airway, inducing sputum)
□ Patient spit/coughed/vomited
□ Bleeding vessel
□ Phlebotomy
□ Changing dressing/wound care
□ Surgical procedure (e.g., all surgical procedures including C-section)
□ Cleaning/transporting contaminated equipment
□ Tube placement/removal/manipulation (e.g., chest, endotracheal, NG, rectal, urine catheter)
□ Endoscopic procedures
□ Vaginal delivery
□ IV or arterial line insertion/removal/manipulation
□ Other (specify): _______________________________
□ Irrigation procedures
□ Unknown
□ Manipulating blood tube/bottle/specimen container


3. Barriers used by the worker at the time of exposure: (Check all that apply)
□ Face shield
□ Mask/respirator
□ Gloves
□ Other (specify): _______________________________
□ Goggles
□ No barriers
□ Gown


Section IV – Bite
1. Wound description: (Check one)

□ No spontaneous bleeding
□ Tissue avulsed
□ Spontaneous bleeding
□ Unknown

2. Activity/event when exposure occurred: (Check one)

□ During dental procedure
□ Assault by patient
□ During oral examination
□ Other (specify): _______________________________
□ Providing oral hygiene
□ Unknown
□ Providing non-oral care to patient

Exposure to Blood/Body Fluids
Page 6 of 7
Note: Section V-IX are required when following the protocols for Exposure Management.
Section V – Source Information
1. Was the source patient known?    □ Y     □ N

2. Was HIV status known at the time of exposure?   □ Y     □N

3. Check the test results for the source patient (P=positive, N=negative, I=indeterminate, U=unknown, R=refused, NT=not tested)
Hepatitis B
P
N
I
U
R
NT
HBsAg






HBeAg






Total anti-HBc






Anti-HBs






Hepatitis C
Anti-HCV EIA






Anti-HCV supplemental






PCR-HCV RNA






HIV
EIA, ELISA






Rapid HIV






Confirmatory test






Section VI – For HIV Infected Source
1. Stage of disease: (Check one)
□ End-stage AIDS
□ Other symptomatic HIV, not AIDS
□ AIDS
□ HIV infection, no symptoms
□ Acute HIV illness
□ Unknown

2. Is the source patient taking anti-retroviral drugs?   □ Y     □ N     □ U

2a. If yes, indicate drug(s):
__________
__________
__________
__________
__________
__________

3. Most recent CD4 count: ________mm3
Date: ____ /______ (mo/yr)

4. Viral load: _____ copies/ml  _____ undetectable
Date: ____ /______ (mo/yr)
Section VII – Initial Care Given to Healthcare Worker
1. HIV postexposure prophylaxis:
Offered?   □ Y    □ N    □ U
Taken:  □ Y    □ N    □ U    (If Yes, complete PEP form)

2. HBIG given?                       □ Y    □ N    □ U
Date administered: ____ /____ /_______

3. Hepatitis B vaccine given:  □ Y    □ N    □ U
Date 1st dose administered: ____ /____ /_______

4. Is the HCW pregnant?        □ Y    □ N    □ U

4a. If yes, which trimester?  □ 1    □ 2     □ 3    □ U
Exposure to Blood/Body Fluids
Page 7 of 7
Section VIII – Baseline Lab Testing
Was baseline testing performed on the HCW?  □ Y    □ N    □ U     If Yes, indicate results
Test
Date
Result
Test
Date
Result
HIV EIA
__ /__ /____
P
N
I
R
ALT
__ /__ /____
____ IU/L
HIV Confirmatory
__ /__ /____
P
N
I
R
Amylase
__ /__ /____
____ IU/L
Hepatitis C anti-HCV-EIA
__ /__ /____
P
N
I
R
Blood glucose
__ /__ /____
____ mmol/L
Hepatitis C anti-HCV-supp
__ /__ /____
P
N
I
R
Hematocrit
__ /__ /____
____ %
Hepatitis C PRC HCV RNA
__ /__ /____
P
N
I

Hemoglobin
__ /__ /____
____ gm/L
Hepatitis B HBs Ag
__ /__ /____
P
N
I

Platelets
__ /__ /____
____ x109/L
Hepatitis B IgM anti-HBc
__ /__ /____
P
N
I

Blood cells in Urine
__ /__ /____
____ #/mm3
Hepatitis B Total anti-HBc
__ /__ /____
P
N
I

WBC
__ /__ /____
____ x109/L
Hepatitis B Anti-HBs
__ /__ /____
_____ mIU/mL
Creatinine
__ /__ /____
____ μmol/L
Result Codes: P=Positive, N=Negative, I=Indeterminate, R=Refused
Other: __________
__ /__ /____
___________

Section IX – Follow-up
1. Is it recommended that the HCW return for follow-up of this exposure? □ Y    □ N
1a. If Yes, will follow-up be performed at this facility?  □ Y    □ N

Section X – Narrative
In the worker’s words, how did the injury occur?






Section XI – Prevention
In the worker’s words, what could have prevented the injury?






Custom Fields
Label
Label
_________________________
____/____/_____
_________________________
____/____/_____
_________________________
______________
_________________________
______________
_________________________
______________
_________________________
______________
_________________________
______________
_________________________
______________
_________________________
______________
_________________________
______________
_________________________
______________
_________________________
______________
Comments